Nomi Health Logo

Non-Disclosure Agreement

Nomi Health Confidentiality Agreement

1Recipient Information
Please provide your information as the receiving party
2Agreement Terms
Please review the complete Non-Disclosure Agreement below
NON-DISCLOSURE AGREEMENT

This Non-Disclosure Agreement ("Agreement") is entered into as of December 17, 2025 (the "Effective Date") by and between:

1. Background

The Company and Recipient (collectively, the "parties") intend to engage in discussions and negotiations concerning the possible establishment of a business relationship between them. In the course of such discussions and negotiations and in the course of any such business relationship, it is anticipated that each party will disclose or deliver to the other party and to the other party's directors, officers, employees, agents or advisors (including, without limitation, attorneys, accountants, consultants, bankers, financial advisors and members of advisory boards) (collectively, "Representatives") certain of its trade secrets or confidential or proprietary information for the purposes of enabling the other party to evaluate the feasibility of such business relationship and to perform its obligations and exercise its rights under any such business relationship that is agreed to between the parties (the "Purposes"). The parties have entered into this Agreement in order to assure the confidentiality of such trade secrets and confidential or proprietary information in accordance with the terms of this Agreement. As used in this Agreement, the party disclosing Proprietary Information (as defined below) is referred to as the "Disclosing Party"; the party receiving such Proprietary Information is referred to as the "Recipient".

2. Proprietary Information

As used in this Agreement, the term "Proprietary Information" shall mean all trade secrets or confidential or proprietary information designated as such in writing by the Disclosing Party, whether by letter or by the use of an appropriate proprietary stamp or legend, prior to or at the time any such trade secret or confidential or proprietary information is disclosed by the Disclosing Party to the Recipient. Notwithstanding the foregoing, information which is orally or visually disclosed to the Recipient by the Disclosing Party, or is disclosed in writing without an appropriate letter, proprietary stamp or legend, shall constitute Proprietary Information if (i) it would be apparent to a reasonable person, familiar with the Disclosing Party's business and the industry in which it operates, that such information is of a confidential or proprietary nature the maintenance of which is important to the Disclosing Party or if (ii) the Disclosing Party, within 30 days after such disclosure, delivers to the Recipient a written document or documents describing such Proprietary Information and referencing the place and date of such oral, visual or written disclosure and the names of the Representatives of the Recipient to whom such disclosure was made.

In addition, the term "Proprietary Information" shall be deemed to include: (a) any notes, analyses, compilations, studies, interpretations, memoranda or other documents prepared by the Recipient or its Representatives which contain, reflect or are based upon, in whole or in part, any Proprietary Information furnished to the Recipient or its Representatives pursuant hereto; and (b) the existence or status of, and any information concerning, the discussions between the parties concerning the possible establishment of a business relationship.

3. Scope of Agreement

This Agreement shall apply to all Proprietary Information disclosed between the parties hereto, whether before, on or after the date hereof.

4. Use and Disclosure of Proprietary Information

The Recipient and its Representatives shall use the Proprietary Information of the Disclosing Party only for the Purposes and such Proprietary Information shall not be used for any other purpose without the prior written consent of the Disclosing Party. Without limitation of the foregoing, the Recipient shall not cause or permit reverse engineering of any Proprietary Information or decompilation or disassembly of any software programs which are part of the Proprietary Information.

The Recipient and its Representatives shall hold in confidence, and shall not disclose any Proprietary Information of the Disclosing Party; provided, however, that (i) the Recipient may make any disclosure of such information to which the Disclosing Party gives its prior written consent; and (ii) any of the Proprietary Information may be disclosed by the Recipient to its Representatives who need to know such information in connection with the Purposes, or to prospective investors, lenders or acquirors as part of their due diligence investigations, and in each case who are informed of the confidential nature of such information and of the terms of this Agreement. In any event, the Recipient shall be responsible for any breach of this Agreement by any of its Representatives or such parties, and agrees, at its sole expense, to take reasonable measures to restrain its Representatives and such parties from prohibited or unauthorized disclosure or use of the Proprietary Information.

Notwithstanding anything contained in this Agreement to the contrary, this Agreement shall not prohibit the Recipient from disclosing Proprietary Information of the Disclosing Party to the extent required in order for the Recipient to comply with applicable laws and regulations, provided that the Recipient provides prior written notice of such required disclosure to the Disclosing Party and takes reasonable and lawful actions to avoid and/or minimize the extent of such disclosure.

5. Limitation on Obligations

The obligations of the Recipient specified in Section 4 shall not apply, and the Recipient shall have no further obligations, with respect to any Proprietary Information to the extent the Recipient can demonstrate, by clear and convincing evidence, that such Proprietary Information:

  • (a) is generally known to the public at the time of disclosure or becomes generally known without the Recipient or its Representatives violating this Agreement;
  • (b) is in the Recipient's possession at the time of disclosure;
  • (c) becomes known to the Recipient through disclosure by sources other than the Disclosing Party without such sources violating any confidentiality obligations to the Disclosing Party; or
  • (d) is independently developed by the Recipient without reference to or reliance upon the Disclosing Party's Proprietary Information.

6. Ownership of Proprietary Information

The Recipient agrees that it shall not receive any right, title or interest in, or any license or right to use, the Disclosing Party's Proprietary Information or any patent, copyright, trade secret, trademark or other intellectual property rights therein, by implication or otherwise. Each of the parties hereto represents, warrants and covenants that the trade secrets which it discloses to the other party pursuant to this Agreement have not been stolen, appropriated, obtained or converted without authorization.

7. Return of Proprietary Information

The Recipient shall, upon the written request of the Disclosing Party, return to the Disclosing Party all Proprietary Information received by the Recipient or its Representatives from the Disclosing Party (and all copies and reproductions thereof). In addition, the Recipient shall destroy: (i) any notes, reports or other documents prepared by the Recipient which contain Proprietary Information of the Disclosing Party; and (ii) any Proprietary Information of the Disclosing Party (and all copies and reproductions thereof) which is in electronic form or cannot otherwise be returned to the Disclosing Party. Alternatively, upon written request of the Disclosing Party, the Recipient shall destroy all Proprietary Information received by the Recipient or its Representatives from the Disclosing Party (and all copies and reproduction thereof) and any notes, reports or other documents prepared by the Recipient which contain Proprietary Information of the Disclosing Party.

Notwithstanding the return or destruction of the Proprietary Information, the Recipient and its Representatives will continue to be bound by their obligations of confidentiality and other obligations hereunder. The Recipient's legal counsel may retain one copy of the Disclosing Party's Proprietary Information for archival purposes only.

8. Non-Circumvention

In connection with this Agreement, each Party (in such role, the "Introducing Party") expects to introduce the other Party and its Representatives (in such role, the "Introduced Party") to the Introducing Party's contacts. Without the Introducing Party's prior written consent, the Introduced Party will not, and will not permit its Representatives to, contact or solicit individuals, institutions, corporations or other entities, buyers or sellers introduced by Introducing Party or learned of through the Introducing Party or its network ("Introduced Contacts"), in each case in connection any business purpose (the "Business").

During the term of this Agreement and for a period of 24 months after the termination or expiration of the Term (the "Transaction Period"), the Introduced Party agrees for itself and its Representatives that it will and will cause its Representatives and affiliates to promptly refer to the Introducing Party all inquiries, proposals and offers from Introduced Contacts or referrals from Introduced Contacts. The Introduced Party hereby agrees that neither it nor its principals, officers, directors, employees, contract personnel, agents, affiliates or successors, will make any contact with, engage, deal with or otherwise be involved in any future transaction(s) with any entity, financial institution or related party that is an Introduced Contact without the prior written consent of the Introducing Party.

Each Party agrees to inform the other party promptly, in writing, regarding any agreement, arrangement, meeting, contact, undertaking, act or intent, and situations involving prospective buyers, sellers, investors, lenders or borrowers, in each case involving or referring to Business or potential Business during the Transaction Period. The Parties agree to act in good faith at all times under this Agreement.

9. Term and Termination

This Agreement is effective as of the Effective Date and shall continue in full force and effect until the two (2) year anniversary thereof. Either party may terminate this Agreement, for any reason or for no reason, upon fifteen (15) days prior written notice to the other party. Notwithstanding such expiration or termination, the obligations of the Recipient specified in Section 4 shall continue with respect to a particular item of Proprietary Information until the fifth (5th) anniversary of the disclosure of such Proprietary Information to Recipient hereunder; provided, however, that such obligations shall continue with respect to any Proprietary Information that is software (whether in source code or object code form) or that constitutes a trade secret until and unless one of the exceptions set forth in Section 5 applies to such item of Proprietary Information.

10. Miscellaneous

(a) Entire Agreement: This Agreement supersedes all prior agreements, written or oral, between the parties relating to the subject matter of this Agreement. This Agreement may not be modified, changed or discharged, in whole or in part, except by an agreement in writing signed by the parties.

(b) Binding Effect: This Agreement will be binding upon and inure to the benefit of the parties and their respective heirs, successors and assigns.

(c) Governing Law: This Agreement shall be construed and interpreted in accordance with the internal laws of the State of Washington, without giving effect to the principles of conflicts of law thereof.

(d) Remedies: The provisions of this Agreement are necessary for the protection of the business and goodwill of the parties and are considered by the parties to be reasonable for such purpose. The Recipient agrees that any breach of this Agreement will cause the Disclosing Party substantial and irreparable injury and, therefore, in the event of any such breach, in addition to other remedies which may be available, the Disclosing Party shall have the right to specific performance and other injunctive and equitable relief.

(e) Execution: For the convenience of the parties, this Agreement may be executed by facsimile and in counterparts, each of which shall be deemed to be an original, and both of which taken together, shall constitute one agreement binding on both parties.

BY SIGNING BELOW, THE RECIPIENT ACKNOWLEDGES THAT THEY HAVE READ, UNDERSTOOD, AND AGREE TO BE BOUND BY ALL TERMS AND CONDITIONS OF THIS NON-DISCLOSURE AGREEMENT.

3Digital Signature
By signing below, you agree to the terms of this Non-Disclosure Agreement

By typing your name above, you are providing your digital signature

Your IP address will be recorded for legal verification purposes

This NDA will be securely transmitted to Nomi Health upon submission.

For questions, please contact Nomi Health directly.